Systems, devices, and methods including implantable devices with anti-microbial properties
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61L-002/00
A61L-029/08
A61L-002/232
A61L-002/24
A61L-002/26
A61L-027/54
A61L-031/08
A61L-017/14
A61L-027/28
A61L-027/30
A61L-029/00
A61L-029/16
B82Y-005/00
B82Y-030/00
A61L-002/08
A61L-002/14
B82Y-040/00
출원번호
US-0931926
(2011-02-14)
등록번호
US-9474831
(2016-10-25)
발명자
/ 주소
Boyden, Edward S.
Diaz, Roy P.
Hyde, Roderick A.
Kare, Jordin T.
Sweeney, Elizabeth A.
Wood, Jr., Lowell L.
출원인 / 주소
GEARBOX, LLC
대리인 / 주소
Honz, Daniel J.
인용정보
피인용 횟수 :
0인용 특허 :
179
초록
Systems, devices, methods, and compositions are described for providing an actively controllable implant configured to, for example, monitor, treat, or prevent microbial growth or adherence to the implant.
대표청구항▼
1. An insertable device system, comprising: a body structure having an outer surface and an inner surface defining one or more fluid-flow passageways;at least one independently addressable and actively controllable anti-microbial nanostructure including a nanofiber of a surface switchable between a
1. An insertable device system, comprising: a body structure having an outer surface and an inner surface defining one or more fluid-flow passageways;at least one independently addressable and actively controllable anti-microbial nanostructure including a nanofiber of a surface switchable between a zwitterionic state and a non-zwitterionic state and projecting from at least one of the outer surface or the inner surface of the body structure; andcircuitry operably coupled to the nanofiber and configured to activate the nanofiber based on at least one signal from a sensor configured to determine the presence of at least one microorganism on at least one of the independently addressable and actively controllable anti-microbial nanostructure of the body structure. 2. The insertable device system of claim 1, further including a controller operably coupled to the at least one sensor, the controller configured to actuate at least one of the independently addressable and actively controllable anti-microbial nanostructure in response to at least one of a scheduled program, external command, history of a previous presence of a microorganism, or history of a previous activation. 3. The insertable device system of claim 1, further including circuitry configured for determining the presence of at least one microorganism on the body structure subsequent to a first round of activation of the at least one independently addressable and actively controllable anti-microbial nanostructure. 4. The insertable device system of claim 3, wherein the circuitry configured for determining the presence of at least one microorganism includes at least one sensor including an identification code. 5. The insertable device system of claim 4, wherein the at least one sensor is configured to implement instructions addressed to the at least one identification code. 6. The insertable device system of claim 3, wherein the circuitry configured for determining the presence of at least one microorganism includes at least one sensor operably coupled to a microorganism biomarker array. 7. The insertable device system of claim 3, wherein the circuitry configured for determining the presence of at least one microorganism includes at least one of an electrochemical transducer, optical transducer, biochemical transducer, ultrasonic transducer, piezoelectric transducer, or thermal transducer. 8. The insertable device system of claim 3, wherein the circuitry configured for determining the presence of at least one microorganism includes at least one thermal detector, photovoltaic detector, or photomultiplier detector. 9. The insertable device system of claim 3, wherein the circuitry configured for determining the presence of at least one microorganism includes at least one of a density sensor, refractive index sensor, surface plasmon resonance sensor, biomass sensor, electrochemical sensor, fluid-flow sensor, or biochemical sensor. 10. The insertable device system of claim 3, wherein the circuitry configured for determining the presence of at least one microorganism includes a microbial component capture layer. 11. The insertable device system of claim 10, wherein the microbial component capture layer includes an array of different binding molecules that specifically bind one or more components on at least one microorganism. 12. The insertable device system of claim 1, further including circuitry configured for altering the type of response of the independently addressable and actively controllable anti-microbial nanostructure based on the determination of the presence of at least one microorganism on the body structure subsequent to a first round of activation. 13. The insertable device system of claim 1, further including electrically activating means for concurrently or sequentially electrically activating two or more of the at least one independently addressable and actively controllable anti-microbial nanostructure determined to have at least one microorganism present thereon. 14. The insertable device system of claim 1, further including at least one computing device. 15. The insertable device system of claim 14, wherein the at least one computing device is remote to the insertable device. 16. The insertable device system of claim 14, further including one or more instructions that when executed on the at least one computing device cause the at least one computing device to generate at least one output to a user. 17. The insertable device system of claim 16, wherein the at least one output includes at least one of a treatment protocol, identification of a detected microorganism, status of the insertable device, or location of a detected microorganism. 18. The insertable device system of claim 16, wherein the user includes at least one entity. 19. The insertable device system of claim 18, wherein the at least one entity includes at least one person or computer. 20. The insertable device system of claim 16, wherein the at least one output includes output to a user readable display. 21. The insertable device system of claim 20, wherein the user readable display includes a human readable display. 22. The insertable device system of claim 20, wherein the user readable display includes one or more active displays. 23. The insertable device system of claim 20, wherein the user readable display includes one or more passive displays. 24. The insertable device system of claim 20, wherein the user readable display includes one or more of a numeric format, graphical format, or audio format. 25. An insertable device system, comprising: a body structure having an outer surface and an inner surface defining one or more fluid-flow passageways;at least one independently addressable and actively controllable anti-microbial nanostructure including a nanofiber of a surface switchable between a zwitterionic state and a non-zwitterionic state and projecting from at least one of the outer surface or the inner surface of the body structure;at least one sensor configured to detect one or more microorganisms present on the body structure; andmeans for determining the presence of at least one microorganism on at least one of the independently addressable and actively controllable anti-microbial nanostructure of the body structure. 26. An insertable device system, comprising: a computer-recordable medium bearing:a body structure having an outer surface and an inner surface defining one or more fluid-flow passageways;at least one independently addressable and actively controllable anti-microbial nanostructure including a nanofiber of a surface switchable between a zwitterionic state and a non-zwitterionic state and; andone or more instructions for determining the presence of at least one microorganism on at least one of the at least one independently addressable and actively controllable anti-microbial nanostructure of the body structure. 27. The insertable device system of claim 26, wherein the at least one independently addressable and actively controllable anti-microbial nanostructure is configured to be actuated by the presence of at least one microorganism. 28. An insertable device system, comprising: a computer-recordable medium bearing:a body structure having an outer surface and an inner surface defining one or more fluid-flow passageways;at least one independently addressable and actively controllable anti-microbial nanostructure including a nanofiber of a surface switchable between a zwitterionic state and a non-zwitterionic state; andone or more instructions for controlling the at least one independently addressable and actively controllable anti-microbial nanostructure of the body structure. 29. A method of reducing microbial growth of at least a portion of an insertable device, comprising: activating via control circuitry at least one independently addressable and actively controllable anti-microbial nanostructure including a nanofiber of a surface switchable between a zwitterionic state and a non-zwitterionic state and projecting from at least one of the outer surface or the inner surface of a body structure of an insertable device, the body structure defining one or more fluid-flow passageways, based on at least one of an automatically detected biomarker or a heuristically determined parameter associated with at least one microorganism. 30. The method of claim 29, wherein activating the at least one actively controllable anti-microbial nanostructure includes activating a spatially patterned anti-microbial nanostructure. 31. The method of claim 29, wherein activating the at least one actively controllable anti-microbial nanostructure includes activating a temporally patterned anti-microbial nanostructure. 32. The method of dam 29, wherein activating the at least one actively controllable anti-microbial nanostructure includes activating a spatially patterned anti-microbial nanostructure based on at least one of detected fluorescence, detected impedance, detected optical reflectance, detected thermal transfer, detected change in conductance, or detected change in index of refraction. 33. The method of claim 29, wherein activating the at least one actively controllable anti-microbial nanostructure includes activating a spatially patterned anti-microbial nanostructure based on a detected pH. 34. The method of claim 29, wherein activating the at least one actively controllable anti-microbial nanostructure includes activating a spatially patterned anti-microbial nanostructure based on a detected microbial component of at least one microorganism. 35. The method of claim 29, wherein activating the at least one actively controllable anti-microbial nanostructure is initiated at least one of prior to, during, or subsequent to insertion of the insertable device into a biological subject. 36. The method of claim 29, wherein the method includes electrically activating a computing device to execute the method. 37. The method of claim 29, further including generating at least one output to a user. 38. The method of claim 37, wherein generating at least one output to the user includes electrically activating at least one of a treatment protocol, identification of a detected microorganism, status of the insertable device, or location of a detected microorganism. 39. The method of claim 37, wherein generating at least one output to the user includes generating at least one output to at least one entity. 40. The method of claim 37, wherein the at least one entity includes at least one person or computer. 41. The method of claim 37, wherein the at least one output includes at least one output to a user readable display. 42. The method of claim 41, wherein the user readable display includes a human readable display. 43. The method of claim 41, wherein the user readable display includes one or more active displays. 44. The method of claim 41, wherein the user readable display includes one or more passive displays. 45. The method of claim 41, wherein the user readable display includes one or more of a numeric format, graphical format, or audio format.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (179)
Menon I. Aravindakshan,CAX ; Haberman Herbert F.,CAX, 33 Lipomelanin sunscreen composition.
Seeberger,Michael; Vanderlinde,Scott; Kalgren,James; Lindh,Par; Larsen Kelly,Kristine M.; Lanz,Mitchell; Thompson,Jeffrey M.; Dyjach,John A., Adaptive software configuration for a medical device.
Smith, Patrick J.; Jones, Jason A.; McGonagle, Kevin A., Apparatus and method for activation of a digital signal processor in an idle mode for interprocessor transfer of signal groups in a digital signal processing unit.
Snaper Alvin A. (2800 Cameo Cir. Las Vegas NV 89107) Gelbaum Bernard R. (127 Ruskin Rd. Buffalo NY 14226) Gelbaum Daniel (48 Bellevue San Rafael CA 94901), Bio-operable power source.
Panero,Stefania; Abbati,Gianluca; Renier,Davide; Crescenzi,Vittorio, Electrically conductive polymeric biomaterials, the process for their preparation and the use thereof in the biomedical and healthcare field.
Oksman Henry C. (140 Morris La. Scarsdale NY 10583) Eisner Joseph (219 E. 32nd St. New York NY 10016), Electrochemical contact lens disinfection and neutralization system.
Nova Michael P. ; Parandoosh Zahra ; Senyei Andrew E. ; Xiao Xiao-Yi ; David Gary S. ; Satoda Yozo ; Zhao Chanfeng ; Potash Hanan, Matrices with memories and uses thereof.
Wilk Peter J. (185 West End Ave. New York NY 10023) Tiefenbrun Jonathan (62 Country Rd. Mamaroneck NY 10543), Method and apparatus for catheter sterilization.
Frank R. Prosl ; Hans-Dietrich Polaschegg AT; Brian K. Estabrook ; Klaus Sodemann DE, Method and apparatus for overcoming infection in a tissue pocket surrounding an implanted device.
Khalil,Omar S.; Yeh,Shu jen; Kantor,Stanislaw; Hanna,Charles F.; Shain,Eric B., Method for optical measurements of tissue to determine disease state or concentration of an analyte.
Van Rijn, Cornelis Johannes Maria; Vogelaar, Laura; Nijdam, Wietze; Barsema, Jonathan Nathaniel; Wessling, Matthias, Method of making a product with a micro or nano sized structure and product.
Silver Jerry (Lyndhurst OH) Smith George M. (Cleveland OH) Jacobberger James W. (Chesterland OH), Method of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use o.
Richards, Amy C.; Santini, Jr., John T.; Cima, Michael J.; Langer, Robert S., Microchip devices for delivery of molecules and methods of fabrication thereof.
John T. Santini, Jr. ; Charles E. Hutchinson ; Scott A. Uhland ; Michael J. Cima ; Robert S. Langer ; Dennis Ausiello, Microfabricated devices for the delivery of molecules into a carrier fluid.
Santini, Jr., John T.; Sheppard, Jr., Norman F.; Young, Chung Chang; Langer, Robert S., Microfabricated devices for the storage and selective exposure of chemicals and devices.
Boni Lawrence T. ; Janoff Andrew S. ; Minchey Sharma R. ; Perkins Walter R. ; Swenson Christine E. ; Ahl Patrick L. ; Davis Thomas S., Pharmaceutical compositions containing interdigitation-fusion liposomes and gels.
Connelly,Patrick R.; Foster,Thomas H.; Weiner,Michael L.; Custer,Andrew W., Process for identifying cancerous and/or metastatic cells of a living organism.
Bae You H. (Salt Lake City UT) Kim Sung W. (Salt Lake City UT) Valuev Lev I. (Moscow SUX), Pulsatile drug delivery device using stimuli sensitive hydrogel.
Schulman Joseph H. (Santa Clarita CA) Mann Alfred E. (Beverly Hills CA) Byers Charles L. (Canyon Country CA) Love Jack W. (Santa Barbara CA), Replaceable catheter system for physiological sensors, stimulating electrodes and/or implantable fluid delivery systems.
Wong Tai-Ting (7th Fl. ; No. 320-3 ; Shin Pai Rd. ; Sec. 2 Taipei) Lee Liang-Shong (Taipei) Niu Gregory C. (Taipei TWX), Shunting device adopted in the intracranial shunting surgical operation for the treatment of hydrocephalus.
Brennan, Anthony B; Baney, Ronald H.; Carman, Michelle L.; Estes, Thomas G.; Feinberg, Adam W.; Wilson, Leslie H.; Schumacher, James F., Surface topographies for non-toxic bioadhesion control.
Currie, John F.; Paranjape, Makarand; Peck, Carl C.; White, Robert; Schneider, Thomas W., Systems and methods for monitoring health and delivering drugs transdermally.
Greenfeld Albert R. (31430 Glenbridge Rd. Westlake Village CA 91361) Reis Herbert (Thousand Oaks CA) Tittmann Bernhard R. (Thousand Oaks CA), Ultrasonic self-cleaning catheter system for indwelling drains and medication supply.
Pennell Phillip E. (Denver CO) Blackmore John M. (Redwood City CA) Allen Mark D. (Lakewood CO), Viscoelastic fluid for use in spine and general surgery and other surgery and therapies and method of using same.
Kittrell Carter (Cambridge MA) Willett Robert L. (Billings MT) de los Santos-Pacheco Cynthia (Cambridge MA) Kenny Leo T. (New Bedford MA) Feld Michael S. (Waban MA), Visible fluorescence spectral diagnostic for laser angiosurgery.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.